News
Alembic Pharma received the final approval from the USFDA for its abbreviated new drug application (ANDA) for Carbamazepine ...
Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback